Further observations on the inhibition of tumor growth by C. parvum with cyclophosphamide. VII. Effect of treatment prior to primary tumor removal on the growth of distant tumor

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Cancer

• Publication date

  1979-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(197902)43:2<451::AID-CNCR2820430208>3.0.CO;2-HPMID 421172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BCG and cancer (first of two parts).

  2010cited by this paper
• Immunotherapy of malignant melanoma.

  1980cited by this paper
• Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation

  1978cited by this paper
• Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.

  1978cited by this paper
• Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.

  1978cited by this paper
• Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.

  1977cited by this paper
• Immunotherapy of metastatic cancer in guinea pigs: failure of intralesional BCG to influence the results of radical surgery.

  1977cited by this paper
• Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system.

  1976cited by this paper
• Intra‐lesional injection of immunostimulants in bilateral rat tumors

  1976cited by this paper
• Intralesional immunotherapy of melanoma with BCG.

  1976cited by this paper
• A proper sequence for the treatment of B16 melanoma: chemotherapy, surgery, and immunotherapy.

  1976cited by this paper
• Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours

  1976cited by this paper
• The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.

  1976cited by this paper
• The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases

  1976cited by this paper
• Report on 414 Cases of Human Tumors Treated with Corynebacteria

  1975cited by this paper
• Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.

  1975cited by this paper
• The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum.

  1975cited by this paper
• Inhibitory effect of prolonged corynebacterium parvum and cyclophosphamide administration on the growth of established tumors

  1975cited by this paper
• Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents.

  1975cited by this paper
• Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.

  1975cited by this paper
• BCG lmmunotherapy of Malignant Melanoma: Summary of a Seven-year Experience

  1974cited by this paper
• Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.

  1974cited by this paper
• Rejection of tumors and metastases in fischer 344 rats following intratumor administration of killed corynebacterium parvum

  1974cited by this paper
• Regression of a transplantable hamster melanoma by intralesional injections of Corynebacterium granulosum.

  1974cited by this paper
• Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.

  1974cited by this paper
• BCG and cancer.

  1974cited by this paper
• BCG therapy given as an adjuvant to surgery: prevention of death from metastases from mammary adenocarcinoma in rats.

  1974cited by this paper
• Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.

  1973cited by this paper
• Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.

  1973cited by this paper
• Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system.

  1973cited by this paper
• Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.

  1972cited by this paper
• Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigencity of the Tumour

  1972cited by this paper
• Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.

  1972cited by this paper
• Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.

  1972cited by this paper
• Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy.

  1970cited by this paper
• Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.

  1970cited by this paper
• Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

  1969cited by this paper

• Tumor reductive therapies and antitumor immunity.

  2017cites this paper
• Tumor reductive therapies and antitumor immunity

  2017cites this paper
• What's new in neoadjuvant therapy for breast cancer?

  2010cites this paper
• Preoperative Chemotherapy in Primary O perable Breast Cancer: Resu lts From the Eu ropean O rganization for Research and Treatment of Cancer Trial 10902

  2006cites this paper
• Preoperative Chemotherapy in Primary O perable B reast Cancer: R esu lts From the Eu ropean O rganization for R esearch and Treatment of Cancer Trial 10902

  2006cites this paper
• State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments

  2005cites this paper
• State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments Aktueller Stand der neoadjuvanten Chemotherapie des Mammakarzinoms: Gründe, Resultate und neuere Entwicklungen

  2005cites this paper
• Host resistance to metastasis from mouse mammary carcinomas

  2004cites this paper
• Preoperative chemotherapy and endocrine therapy in patients with breast cancer.

  2004cites this paper
• Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery

  2002cites this paper
• Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

  2001cites this paper
• Preoperative chemotherapy for gastric cancer: a prospective study with at least 1 year follow-up.

  1986cites this paper
• Perioperative Chemotherapy

  1985cites this paper
• CHAPTER 9 – NATURAL AND INDUCED RESISTANCE TO METASTASIS FROM MOUSE MAMMARY CARCINOMAS

  1985cites this paper
• Preoperative chemotherapy: advantages and clinical application in stage III breast cancer.

  1985cites this paper
• [Corynebacteria--stimulators of antitumor resistance].

  1984cites this paper
• Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.

  1981cites this paper
• Preoperative chemotherapy for operable solid tumours.

  1981cites this paper
• Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide—VIII Effect of tumor radiation prior to therapy

  1978cites this paper
• Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII.

  1978cites this paper